Western Financial Corp/Ca Abb Vie Inc. Transaction History

Western Financial Corp/Ca

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $24,080 - $27,119	-175 Reduced 2.87%	5,915 $917 Million
Q3 2023 Oct 19, 2023	SELL	$133.59 - $154.65 $81,623 - $94,491	-611 Reduced 9.12%	6,090 $908 Million
Q2 2023 Jul 26, 2023	BUY	$132.51 - $164.9 $12,323 - $15,335	93 Added 1.41%	6,701 $903 Million
Q1 2023 Apr 19, 2023	BUY	$144.61 - $166.54 $28,777 - $33,141	199 Added 3.11%	6,608 $1.05 Billion
Q4 2022 Jan 19, 2023	BUY	$138.31 - $165.87 $886,428 - $1.06 Million	6,409 New	6,409 $1.04 Billion

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Western Financial Corp/Ca, based on Form 13F filings with the SEC.

Stay updated on Western Financial Corp/Ca with notifications on news.